Trials / Withdrawn
WithdrawnNCT05053269
Body Weight Growth After Birth and Bronchopulmonary Dysplasia
Association of Body Weight Growth After Birth and Bronchopulmonary Dysplasia(BPD)
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
- Sex
- All
- Age
- 1 Minute – 1 Day
- Healthy volunteers
- —
Summary
Bronchopulmonary dysplasia (BPD) is one of the most common, complex, and severe diseases in preterm infants. BPD was first described as chronic pulmonary disease in survivors of severe respiratory distress syndrome (RDS) in 1967, which was also called as the "old" BPD. In recent years, the definition for BPD has developed a lot. The National Institute of Child Health and Human Development (NICHD) workshop in 2018 assessed BPD at 36 post-menstrual age (PMA) along with radiographic confirmation and used a severity grading of I-III. Although with effective surfactant supplement and oxygen support, BPD brings a great challenge to neonatologists.
Detailed description
Besides persistent inflammation, prolonged invasive ventilation and oxidative damage. body weight is the one of the most important factors to induce BPD. Poor extrauterine growth is commonly described in extremely preterm infants. But, the relationship of postnatal growth with BPD and respiratory morbidity is not entirely understood. The aim of the present study is to assess whether body weight growth after birth is the risk factor for BPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | good body weight growth | body weight growth after birth is consistent with the growth curve |
| OTHER | poor body weight growth | body weight growth after birth is inconsistent with the growth curve |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2021-09-22
- Last updated
- 2023-05-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05053269. Inclusion in this directory is not an endorsement.